Related references
Note: Only part of the references are listed.Thioguanine in inflammatory bowel disease: Long-term efficacy and safety
Mark G. Ward et al.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2017)
Complementary and Alternative Medicines Used by Patients With Inflammatory Bowel Diseases
Adam S. Cheifetz et al.
GASTROENTEROLOGY (2017)
Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management
Marcus Harbord et al.
JOURNAL OF CROHNS & COLITIS (2017)
Shared Decision Making and Treatment Satisfaction in Japanese Patients with Inflammatory Bowel Disease
Jorg Mahlich et al.
DIGESTIVE DISEASES (2017)
Mesalazine Modified-Release Tablet in the Treatment of Ulcerative Colitis in the Active Phase: A Chinese, Multicenter, Single-Blind, Randomized Controlled Study
Jing Sun et al.
ADVANCES IN THERAPY (2016)
Mesalazine Modified-Release Tablet in the Treatment of Ulcerative Colitis in the Remission Phase: A Chinese, Multicenter, Single-Blind, Randomized Controlled Study
Jing Sun et al.
ADVANCES IN THERAPY (2016)
Defining Disease Severity in Inflammatory Bowel Diseases: Current and Future Directions
Laurent Peyrin-Biroulet et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2016)
Multi Donor Intense Faecal Microbiota Transplantation is an Effective Treatment for Resistant Ulcerative Colitis: A Randomised Placebo-Controlled Trial
Sudarshan Paramsothy et al.
GASTROENTEROLOGY (2016)
Early Course of Inflammatory Bowel Disease in a Population-Based Inception Cohort Study From 8 Countries in Asia and Australia
Siew C. Ng et al.
GASTROENTEROLOGY (2016)
Methotrexate Is Not Superior to Placebo for Inducing Steroid-Free Remission, but Induces Steroid-Free Clinical Remission in a Larger Proportion of Patients With Ulcerative Colitis
Franck Carbonnel et al.
GASTROENTEROLOGY (2016)
Baseline Oral 5-ASA Use and Efficacy and Safety of Budesonide Foam in Patients with Ulcerative Proctitis and Ulcerative Proctosigmoiditis: Analysis of 2 Phase 3 Studies
Brian P. Bosworth et al.
INFLAMMATORY BOWEL DISEASES (2016)
Fecal Microbiota Transplantation for Ulcerative Colitis: A Systematic Review and Meta-Analysis
Yanqiang Shi et al.
PLOS ONE (2016)
Once-daily mesalamine granules for maintaining remission of ulcerative colitis: pooled analysis of efficacy, safety, and prognostic factors
Salam F. Zakko et al.
POSTGRADUATE MEDICINE (2016)
Effectiveness of budesonide MMX (Cortiment) for the treatment of mild-to-moderate active ulcerative colitis: study protocol for a prospective multicentre observational cohort study
Silvio Danese et al.
BMJ OPEN GASTROENTEROLOGY (2016)
Induction of clinical and colonoscopic remission of mild-to-moderate ulcerative colitis with budesonide MMX 9 mg: pooled analysis of two phase 3 studies
W. J. Sandborn et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
L. Peyrin-Biroulet et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2015)
Curcumin in Combination With Mesalamine Induces Remission in Patients With Mild-to-Moderate Ulcerative Colitis in a Randomized Controlled Trial
Alon Lang et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)
Gastroenterologists' Views of Shared Decision Making for Patients with Inflammatory Bowel Disease
Corey A. Siegel et al.
DIGESTIVE DISEASES AND SCIENCES (2015)
Budesonide Foam Induces Remission in Patients With Mild to Moderate Ulcerative Proctitis and Ulcerative Proctosigmoiditis
William J. Sandborn et al.
GASTROENTEROLOGY (2015)
Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial
Paul Moayyedi et al.
GASTROENTEROLOGY (2015)
Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis
Noortje G. Rossen et al.
GASTROENTEROLOGY (2015)
Clinical Practice Guidelines for the Medical Management of Nonhospitalized Ulcerative Colitis: The Toronto Consensus
Brian Bressler et al.
GASTROENTEROLOGY (2015)
OP011. Budesonide MMX(R) 9 mg for Inducing Remission in Patients with Mild-to-Moderate Ulcerative Colitis Not Adequately Controlled with Oral 5-ASAs
Journal of Crohns & Colitis (2015)
The epidemiology of inflammatory bowel disease
Johan Burisch et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2015)
Treatment of IBD: Where We Are and Where We Are Going
Charles N. Bernstein
AMERICAN JOURNAL OF GASTROENTEROLOGY (2015)
964 Agreement Between Deep Histological Remission and Mucosal Healing in Ulcerative Colitis and Predictors of Each Outcome
Britt Christensen et al.
GASTROENTEROLOGY (2014)
Once-daily budesonide MMX in active, mild-to-moderate ulcerative colitis: results from the randomised CORE II study
Simon P. L. Travis et al.
GUT (2014)
Probiotic Mix VSL#3 Is Effective Adjunctive Therapy for Mild to Moderately Active Ulcerative Colitis: A Meta-analysis
Houssam E. Mardini et al.
INFLAMMATORY BOWEL DISEASES (2014)
Effect of Probiotics on Inducing Remission and Maintaining Therapy in Ulcerative Colitis, Crohn's Disease, and Pouchitis: Meta-analysis of Randomized Controlled Trials
Jun Shen et al.
INFLAMMATORY BOWEL DISEASES (2014)
Inflammatory Bowel Disease Cause-specific Mortality: A Primer for Clinicians
Zain Kassam et al.
INFLAMMATORY BOWEL DISEASES (2014)
Ciprofloxacin and probiotic Escherichia coli Nissle add-on treatment in active ulcerative colitis: A double-blind randomized placebo controlled clinical trial
Andreas Munk Petersen et al.
JOURNAL OF CROHNS & COLITIS (2014)
Induction with NCB-02 (curcumin) enema for mild-to-moderate distal ulcerative colitis - A randomized, placebo-controlled, pilot study
Vikas Singla et al.
JOURNAL OF CROHNS & COLITIS (2014)
Combined oral and rectal mesalazine for the treatment of mild-to-moderately active ulcerative colitis: Rapid symptom resolution and improvements in quality of life
Christopher S. J. Probert et al.
JOURNAL OF CROHNS & COLITIS (2014)
Systematic review: Histological remission in inflammatory bowel disease. Is 'complete' remission the new treatment paradigm? An IOIBD initiative
R. V. Bryant et al.
JOURNAL OF CROHNS & COLITIS (2014)
Curcumin and Inflammatory Bowel Disease: Potential and Limits of Innovative Treatments
Liza Vecchi Brumatti et al.
MOLECULES (2014)
Distance management of inflammatory bowel disease: Systematic review and meta-analysis
Vivian W. Huang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Depressive symptoms, self-esteem, HIV symptom management self-efficacy and self-compassion in people living with HIV
L. S. Eller et al.
AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV (2014)
Randomised clinical trial: once- vs. twice-daily prolonged-release mesalazine for active ulcerative colitis
B. Flourie et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
The course of inflammatory bowel disease during pregnancy and postpartum: a prospective European ECCO-EpiCom Study of 209 pregnant women
N. Pedersen et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
Randomised clinical trial: evaluation of the efficacy of mesalazine (mesalamine) suppositories in patients with ulcerative colitis and active rectal inflammation - a placebo-controlled study
M. Watanabe et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
Review article: strategies for the management of chronic unremitting ulcerative colitis
S. J. Mehta et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
A novel mouse model of veno-occlusive disease provides strategies to prevent thioguanine-induced hepatic toxicity
Iulia Oancea et al.
GUT (2013)
P-145 Welcome 54-week Open-label Extension
Brian Feagan et al.
INFLAMMATORY BOWEL DISEASES (2013)
Mesalazine granules 1.5 g once-daily maintain remission in patients with ulcerative colitis who switch from other 5-ASA formulations: a pooled analysis from two randomised controlled trials
G. R. Lichtenstein et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Once-Daily MMX® Mesalamine for Endoscopic Maintenance of Remission of Ulcerative Colitis
Geert D'Haens et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)
The Epidemiology of Colectomy in Ulcerative Colitis: Results From a Population-Based Cohort
Laura E. Targownik et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)
Efficacy of Topical 5-Aminosalicylates in Preventing Relapse of Quiescent Ulcerative Colitis: A Meta-analysis
Alexander C. Ford et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2012)
Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS)
Simon P. L. Travis et al.
GUT (2012)
Strategies in maintenance for patients receiving long-term therapy (SIMPLE): A study of MMX mesalamine for the long-term maintenance of quiescent ulcerative colitis
Sunanda Kane et al.
INFLAMMATORY BOWEL DISEASES (2012)
Mesalazine in left-sided ulcerative colitis: Efficacy analyses from the PODIUM trial on maintenance of remission and mucosal healing
Bernd Bokemeyer et al.
JOURNAL OF CROHNS & COLITIS (2012)
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 1: Definitions and diagnosis
Axel Dignass et al.
JOURNAL OF CROHNS & COLITIS (2012)
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management
Axel Dignass et al.
JOURNAL OF CROHNS & COLITIS (2012)
Shared Decision Making - The Pinnacle of Patient-Centered Care
Michael J. Barry et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Shared decision making and other variables as correlates of satisfaction with health care decisions in a United States national survey
Katherine Elizabeth Glass et al.
PATIENT EDUCATION AND COUNSELING (2012)
Mesalazine granules are superior to Eudragit-L-coated mesalazine tablets for induction of remission in distal ulcerative colitis - a pooled analysis
L. Leifeld et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Randomised clinical trial: delayed-release oral mesalazine 4.8 g/day vs. 2.4 g/day in endoscopic mucosal healing - ASCEND I and II combined analysis
G. R. Lichtenstein et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Glucocorticosteroid Therapy in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis
Alexander C. Ford et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Efficacy of 5-Aminosalicylates in Ulcerative Colitis: Systematic Review and Meta-Analysis
Alexander C. Ford et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
High-dose mesalazine treatment for ulcerative colitis patients who relapse under low-dose maintenance therapy
Takayuki Yamamoto et al.
DIGESTIVE AND LIVER DISEASE (2011)
Prolonged thioguanine therapy is well tolerated and safe in the treatment of ulcerative colitis
Dirk P. van Asseldonk et al.
DIGESTIVE AND LIVER DISEASE (2011)
A Multicenter, Randomized Study to Evaluate the Efficacy and Safety of Mesalamine Suppositories 1 g at Bedtime and 500 mg Twice Daily in Patients with Active Mild-to-Moderate Ulcerative Proctitis
Mark Lamet
DIGESTIVE DISEASES AND SCIENCES (2011)
Early Mucosal Healing With Infliximab Is Associated With Improved Long-term Clinical Outcomes in Ulcerative Colitis
Jean Frederic Colombel et al.
GASTROENTEROLOGY (2011)
Current misunderstandings in the management of ulcerative colitis
Thomas Ochsenkuhn et al.
GUT (2011)
Guidelines for the management of inflammatory bowel disease in adults
Craig Mowat et al.
GUT (2011)
3g mesalazine granules are superior to 9mg budesonide for achieving remission in active ulcerative colitis: A double-blind, double-dummy, randomised trial
Volker Gross et al.
JOURNAL OF CROHNS & COLITIS (2011)
Topical agents for idiopathic distal colitis and proctitis
Ian Craig Lawrance
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2011)
Clinical trial: controlled, open, randomized multicentre study comparing the effects of treatment on quality of life, safety and efficacy of budesonide or mesalazine enemas in active left-sided ulcerative colitis
F. Hartmann et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)
New Drug Delivery Systems in Inflammatory Bowel Disease: MMX™ and Tailored Delivery to the Gut
G. Fiorino et al.
CURRENT MEDICINAL CHEMISTRY (2010)
A Critical Review of Self-Management and Educational Interventions in Inflammatory Bowel Disease
Cate Barlow et al.
GASTROENTEROLOGY NURSING (2010)
Clinical implications of mucosal healing for the management of IBD
Guillaume Pineton de Chambrun et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2010)
Meta-analysis: the efficacy of azathioprine and mercaptopurine in ulcerative colitis
J. P. Gisbert et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Mesalamine Once Daily Is More Effective Than Twice Daily in Patients With Quiescent Ulcerative Colitis
Axel U. Dignass et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2009)
Once daily versus three times daily mesalazine granules in active ulcerative colitis: a double-blind, double-dummy, randomised, non-inferiority trial
W. Kruis et al.
GUT (2009)
Local Application of Tacrolimus in Distal Colitis: Feasible and Safe
Jolanda M. van Dieren et al.
INFLAMMATORY BOWEL DISEASES (2009)
P169 - Higher remission rates in patients with once-daily dosing compared to twice-daily dosing. An analysis of compliance in the once daily vs. twice daily podium trial with mesalazine (Pentasa®) sachets
B. Bokemeyer et al.
Journal of Crohns & Colitis (2009)
Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study
Laurent Beaugerie et al.
LANCET (2009)
Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study)
Inger Camilla Solberg et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2009)
Management of acute severe ulcerative colitis
Glen A Doherty et al.
Expert Review of Gastroenterology & Hepatology (2009)
Review: Ulcerative colitis: current treatment strategies and future prospects
Sagar Garud et al.
Therapeutic Advances in Gastroenterology (2009)
Rectal tacrolimus in the treatment of resistant ulcerative proctitis
I. C. Lawrance et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Erythrocyte-Mediated Delivery of Dexamethasone in Patients With Mild-to-Moderate Ulcerative Colitis, Refractory to Mesalamine: A Randomized, Controlled Study
Fabrizio Bossa et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
An Update on the Epidemiology of Inflammatory Bowel Disease in Asia
Kelvin T. Thia et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Absence of nodular regenerative hyperplasia after low-dose 6-thioguanine maintenance therapy in inflammatory bowel disease patients
N. K. H. de Boer et al.
DIGESTIVE AND LIVER DISEASE (2008)
Risk factors for opportunistic infections in patients with inflammatory bowel disease
Murat Toruner et al.
GASTROENTEROLOGY (2008)
European evidence-based Consensus on the management of ulcerative colitis: Current management
S. P. L. Travis et al.
JOURNAL OF CROHNS & COLITIS (2008)
Rifaximin for the treatment of active pouchitis: A randomized, double-blind, placebo-controlled pilot study
Kim L. Isaacs et al.
INFLAMMATORY BOWEL DISEASES (2007)
Effect of weekend 5-aminosalicylic acid (Mesalazine) enema as maintenance therapy for ulcerative colitis: Results from a Randomized controlled study
Hiroshi Yokoyama et al.
INFLAMMATORY BOWEL DISEASES (2007)
Mucosal healing in inflammatory bowel disease: Results from a Norwegian population-based cohort
Kathrine Frey Froslie et al.
GASTROENTEROLOGY (2007)
Low colectomy rates in ulcerative colitis in an unselected European cohort followed for 10 years
Ole Hoie et al.
GASTROENTEROLOGY (2007)
A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis
Geert D'Haens et al.
GASTROENTEROLOGY (2007)
Effect of once- or twice-daily MMX mesalamine (SPD476) for the induction of remission of mild to moderately active ulcerative colitis
Gary R. Lichtenstein et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)
Once-daily, high-concentration MMX mesalamine in active ulcerative colitis
Michael A. Kamm et al.
GASTROENTEROLOGY (2007)
Medical management of left-sided ulcerative colitis and ulcerative proctitis: Critical evaluation of therapeutic trials
Miguel Regueiro et al.
INFLAMMATORY BOWEL DISEASES (2006)
The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications
J. Satsangi et al.
GUT (2006)
Risk of intestinal cancer in inflammatory bowel disease: A population-based study from Olmsted County, Minnesota
T Jess et al.
GASTROENTEROLOGY (2006)
Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis
S Ardizzone et al.
GUT (2006)
6-thioguanine treatment in inflammatory bowel disease: A critical appraisal by a European 6-TG working party
NKH de Boer et al.
DIGESTION (2006)
Gastrointestinal transit, release and plasma pharmacokinetics of a new oral budesonide formulation
M Brunner et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Infliximab use in Crohn's disease: impact on health care resources in the UK
DR Jewell et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2005)
A multicenter assessment of liver toxicity by MRI and biopsy in IBD patients on 6-thioguanine
J Seiderer et al.
JOURNAL OF HEPATOLOGY (2005)
VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis
R Bibiloni et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
Combined oral and enema treatment with Pentasa (mesalazine) is superior to oral therapy alone in patients with extensive mild/moderate active ulcerative colitis: a randomised, double blind, placebo controlled study
P Marteau et al.
GUT (2005)
Topical treatment of distal active ulcerative colitis with beclomethasone dipropionate or mesalamine - A single-blind randomized controlled trial
P Gionchetti et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2005)
Cancer surveillance in longstanding ulcerative colitis: endoscopic appearances help predict cancer risk
MD Rutter et al.
GUT (2004)
Role of faecal calprotectin as non-invasive marker of intestinal inflammation
F Costa et al.
DIGESTIVE AND LIVER DISEASE (2003)
6-thioguanine can cause serious liver injury in inflammatory bowel disease patients
MC Dubinsky et al.
GASTROENTEROLOGY (2003)
Review article: treatment of mild to moderate ulcerative colitis and pouchitis
P Gionchetti et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2002)
Side effects of corticosteroid therapy
AL Buchman
JOURNAL OF CLINICAL GASTROENTEROLOGY (2001)
Intestinal luminal pH in inflammatory bowel disease: possible determinants and implications for therapy with aminosalicylates and other drugs
SG Nugent et al.
GUT (2001)
Share Paper
